NCT07032324View on ClinicalTrials.gov

A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 8, 2025

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2026

Conditions
B-Cell Non-Hodgkin Lymphoma
Interventions
DRUG

CAR T cells

chimeric antigen receptor T cells

Trial Locations (1)

310003

Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
collaborator

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

lead

Qian Wenbin

OTHER